| Molecular mechanisms on how FABP5 inhibitors promote apoptosis‐induction sensitivity of prostate cancer cells J Zhang, G He, X Jin, BT Alenezi, AA Naeem, SA Abdulsamad, Y Ke Cell Biology International 47 (5), 929-942, 2023 | 6 | 2023 |
| FABP5 can substitute for androgen receptor in malignant progression of prostate cancer cells AA Naeem, SA Abdulsamad, H Zeng, G He, X Jin, J Zhang, BT Alenezi, ... International Journal of Oncology 64 (2), 18, 2023 | 2 | 2023 |
| Peroxisome Proliferator-Activated Receptor Gamma (Pparγ) and Prostate Cancer X Jin, BT Aleniza, G He, H Ma, Q Wei, Y Ke Journal of Oncology And Medicine, 2021 | 1 | 2021 |
| Knowledge and awareness of doctors about herbal drugs in the Northern Border Region of Saudi Arabia E Eltom, W Alenezi, N Zeeni Ann. Clin. Anal. Med 12, 54-59, 2021 | 1 | 2021 |
| Global development on causes, epidemiology, aetiology, and risk factors of prostate cancer: An advanced study BT Alenezi, MH Alsubhi, X Jin, G He, Q Wei, Y Ke | 1 | 2021 |
| Experimental treatment efficacy of dmrFABP5 on prostate cancer singly or in combination with drugs in use SA Abdulsamad, AA Naeem, H Zeng, G He, X Jin, BA Alenezi, J Ai, ... American Journal of Cancer Research 14 (1), 300, 2024 | | 2024 |
| Experimental Treatment of Prostate Cancer Through Knocking Out PPARγ Gene BTA Alenezi PQDT-Global, 2022 | | 2022 |
